Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ
Status:
Recruiting
Trial end date:
2028-08-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, prospective, randomized, stratified, controlled, open-label study
comparing neoadjuvant radiochemotherapy with FLOT versus FLOT chemotherapy alone für patients
with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction
(GEJ)
Phase:
Phase 3
Details
Lead Sponsor:
Universitätsmedizin Mannheim
Collaborators:
Deutsche Krebshilfe e.V., Bonn (Germany) Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest